AllergologyNews.net

Allergology Xagena

Search results for "Xolair"

Data from seven clinical studies demonstrate that in patients with severe allergic asthma who require treatment with oral corticosteroids – indicating that they have a more severe form of the disease ...


Long-term data show that Xolair ( Omalizumab ), a first-in-class monoclonal antibody for treating severe allergic asthma, helped patients to maintain control of their disease and was safe and well-tol ...


European Commission has granted marketing authorization in all 25 EU member states for the novel asthma therapy Xolair ( Omalizumab ). Xolair offers a unique therapeutic approach by blocking the ac ...


A new study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford has shown that an asthma drug accelerates the process of desensitizing patient ...